CDSCO mandates online submission of Period Safety Update Reports (PSURs) through Sugam Portal, offline submissions to be discontinued from 11th March, 2024
With a view to streamline the regulatory submission procedure, the Central Drugs Standards Control... Read More
Dial Schedule M: India’s drug manufacturing practices to undergo major overhaul
If you are a pharmaceutical company in India with a turnover of more than Rs. 250 crores, you only... Read More
Health Ministry permits the sale of Oseltamivir Phosphate and Zanamivir akin to Schedule H1 drugs, with restrictions on sale and export regulated by the Government and DCGI
Ministry of Health and Family Welfare has issued a Notification dated February 5, 2024, revoking... Read More
Public comments invited on proposed amendments to First and Second Schedule of the Drugs and Cosmetics Act till 12th April, 2023
The Ministry of Ayush has invited objections and suggestions on proposed amendments to Schedule I... Read More